Gene Therapy - Developments and Future Perspectives 2011
DOI: 10.5772/20646
|View full text |Cite
|
Sign up to set email alerts
|

Small interfering RNAs: heralding a new era in gene therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 149 publications
0
1
0
Order By: Relevance
“…Finally, DNA aptamers were employed as targeting moieties and designed against the tumour marker MUC1, a mucin glycoprotein overexpressed in several epithelial cancer cells such as colon cancer cells [67]. Since aptamers have a low MW (6 -24 kDa), the RES barely recognized them, allowing NPs to have a longer circulation time [68]. The formation of a protein corona on NPs was evaluated following their incubation with either 10% or 100% FBS.…”
Section: Hyaluronic Acid and Aptamersmentioning
confidence: 99%
“…Finally, DNA aptamers were employed as targeting moieties and designed against the tumour marker MUC1, a mucin glycoprotein overexpressed in several epithelial cancer cells such as colon cancer cells [67]. Since aptamers have a low MW (6 -24 kDa), the RES barely recognized them, allowing NPs to have a longer circulation time [68]. The formation of a protein corona on NPs was evaluated following their incubation with either 10% or 100% FBS.…”
Section: Hyaluronic Acid and Aptamersmentioning
confidence: 99%